D. Schuettler

Inhibition of SphK1 reduces radiation-induced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR/SphK1 crosstalk

G. Piontek, M. Rudelius, G. Brockhoff, 2014, Oncotarget.

Selective inhibition of EGFR downstream signaling reverses the irradiation-enhanced migration of HNSCC cells.

G. Piontek, B. Haller, G. Brockhoff, 2015, American journal of cancer research.